0000899243-23-007801.txt : 20230309
0000899243-23-007801.hdr.sgml : 20230309
20230309213507
ACCESSION NUMBER: 0000899243-23-007801
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20181116
FILED AS OF DATE: 20230309
DATE AS OF CHANGE: 20230309
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Wood Susan Alyson
CENTRAL INDEX KEY: 0001757291
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-09341
FILM NUMBER: 23721456
MAIL ADDRESS:
STREET 1: 845 MORENO AVENUE
CITY: PALO ALTO
STATE: CA
ZIP: 94303
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: ICAD INC
CENTRAL INDEX KEY: 0000749660
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
IRS NUMBER: 020377419
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 98 SPIT BROOK ROAD, SUITE 100
CITY: NASHUA
STATE: NH
ZIP: 03062
BUSINESS PHONE: 603-882-5200
MAIL ADDRESS:
STREET 1: 98 SPIT BROOK ROAD, SUITE 100
CITY: NASHUA
STATE: NH
ZIP: 03062
FORMER COMPANY:
FORMER CONFORMED NAME: HOWTEK INC
DATE OF NAME CHANGE: 19920703
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2018-11-16
0
0000749660
ICAD INC
ICAD
0001757291
Wood Susan Alyson
C/O ICAD, INC.
98 SPIT BROOK ROAD, SUITE 100
NASHUA
NH
03062
1
0
0
0
Director Stock Option (right to buy)
2.89
2018-11-16
4
D
0
40000
D
2023-11-16
Common Stock
40000
0
D
Director Stock Option (right to buy)
2.89
2023-03-07
4
A
0
40000
A
2028-11-16
Common Stock
40000
40000
D
Director Stock Option (right to buy)
3.70
2018-12-31
4
D
0
8738
D
2023-12-31
Common Stock
8738
0
D
Director Stock Option (right to buy)
3.70
2023-03-07
4
A
0
8738
A
2028-12-31
Common Stock
8738
8738
D
The two reported transactions involved an amendment to an outstanding option, resulting in the cancellation of the "old" option and the grant of a replacement option. The option was originally granted on November 16, 2018 and is fully vested as of the date hereof.
The two reported transactions involved an amendment to an outstanding option, resulting in the cancellation of the "old" option and the grant of a replacement option. The option was originally granted on December 31, 2018 and is fully vested as of the date hereof.
On March 7, 2023, the Board of Directors of the Issuer agreed to a modification of the exercise period for certain outstanding stock options granted to the Director in 2018 that would otherwise expire in November 2023 such that they now have an aggregate exercise period of ten years. No other modification was made to the option.
/s/Susan Wood
2023-03-09